Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katherine Giorgio"'
Autor:
Kevin Y. Chang, Katherine Giorgio, Katlin Schmitz, Rob F. Walker, Kurt W. Prins, Marc R. Pritzker, Stephen L. Archer, Pamela L. Lutsey, Thenappan Thenappan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background Digoxin acutely increases cardiac output in patients with pulmonary arterial hypertension (PAH) and right ventricular failure; however, the effects of chronic digoxin use in PAH are unclear. Methods and Results Data from the Minnesota Pulm
Externí odkaz:
https://doaj.org/article/4b2a6de2a2c8424e9f5660eb229ddaee
Autor:
Kailey Urban, Colleen Payton, Blain Mamo, Hannah Volkman, Katherine Giorgio, Lori Kennedy, Yuli Chen Bomber, Kristine Knuti Rodrigues, Janine Young, Carol Tumaylle, Jasmine Matheson, Azadeh Tasslimi, Jessica Montour, Emily Jentes
Publikováno v:
Journal of Immigrant and Minority Health.
Six refugee screening sites collaborated to estimate the prevalence of hepatitis C virus (HCV) antibodies among newly arrived refugees in the United States from 2010 to 2017, identify demographic characteristics associated with HCV antibody positivit
Autor:
Katherine Giorgio, Richard Maclehose, Rob Walker, Faye L Norby, Diego Adrianzen-Herrera, Alvaro Alonso, Neil Zakai, Pamela L Lutsey
Publikováno v:
Circulation. 145
Introduction: Venous thromboembolism (VTE) afflicts approximately 1 million Americans annually. Over the past decade there has been a movement towards outpatient management of uncomplicated acute events and use of oral anticoagulant agents for treatm
Autor:
Diego Adrianzen-Herrera, Pamela L. Lutsey, Katherine Giorgio, Robert F. Walker, Neil A. Zakai
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. 7:100024
Publikováno v:
Blood. 138:3023-3023
Introduction: Multiple myeloma diagnosis is associated with a 10-15% absolute risk of venous thromboembolism (VTE) due to disease-related (i.e., vascular inflammation, hyperviscosity) and treatment-related risk factors (i.e., immunomodulatory drugs [